(Q47284003)

13 January 2018

title

Mucosal immunisation and immunoprophylaxis as potential strategies for prevention of SARS. (English)

1 reference

13 January 2018

0 references

A R Foxwell

1

1 reference

13 January 2018

A W Cripps

series ordinal

2

1 reference

13 January 2018

language of work or name

English

0 references

publication date

1 June 2004

1 reference

13 January 2018

published in

The Lancet

1 reference

13 January 2018

volume

363

1 reference

13 January 2018

issue

9427

1 reference

13 January 2018

page(s)

2102-2103

1 reference

13 January 2018

Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backbone

cites work

1 reference

12 December 2020

A live attenuated bovine parainfluenza virus type 3 vaccine is safe, infectious, immunogenic, and phenotypically stable in infants and children

1 reference

12 December 2020

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

1 reference

12 December 2020

Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.

1 reference

12 December 2020

Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong

1 reference

12 December 2020

Protection from lethal coronavirus infection by affinity-purified spike glycoprotein of murine hepatitis virus, strain A59.

1 reference

12 December 2020

Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines

1 reference

12 December 2020

Evaluation of bovine, cold-adapted human, and wild-type human parainfluenza type 3 viruses in adult volunteers and in chimpanzees.

1 reference

12 December 2020

Bovine parainfluenza virus type 3 (BPIV3) fusion and hemagglutinin-neuraminidase glycoproteins make an important contribution to the restricted replication of BPIV3 in primates

1 reference

12 December 2020

10.1016/S0140-6736(04)16535-5

Identifiers

DOI

1 reference

13 January 2018

0 references

1 reference

13 January 2018